Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.
about
MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cellsTissue factor as a proinflammatory agentProgress in the application of DNA microarraysOvarian cancer, the coagulation pathway, and inflammationPlatelets, coagulation and fibrinolysis in breast cancer progressionTissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells.Impact of venous thromboembolism and anticoagulation on cancer and cancer survivalSubventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlationEvidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer.Use of mouse models to study the role of tissue factor in tumor biologyExpression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.In vivo and in vitro estrogenic and progestagenic actions of Tibolone.Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.Tissue factor, blood coagulation, and beyond: an overview.Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragmentSerum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.Inhibition of tissue factor signaling suppresses tumor growthTissue factor as a novel target for treatment of breast cancerTissue factor expression as a possible determinant of thromboembolism in ovarian cancerTumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment.Utility of epirubicin-incorporating micelles tagged with anti-tissue factor antibody clone with no anticoagulant effect.Photodynamic therapy for gynecological diseases and breast cancerStructure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancerTissue factor, angiogenesis and tumour progression.Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness.Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.Using a cell line breast cancer progression system to identify biomarker candidates.Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells.The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.Pathophysiology and management of thrombosis in cancer: 150 years of progress.Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo.
P2860
Q24598503-908A2C3A-6F37-4C99-ACF8-7426A2D67E66Q24807263-45B6126B-39E5-4BA4-857C-95D34783A21CQ24813217-0B2B4AAD-B1A1-4967-9EBE-8879124A4F5CQ24816796-460B8BD8-A1B4-44E9-921F-CB3CC7F7472EQ26823716-9909D681-D4ED-4CB7-8CE1-75B7AF13E34FQ33322944-BCDB8929-36C7-4127-B205-055E0332B416Q33561203-1BE3527C-8496-43AC-AFFA-C4B1D7F233ABQ33684168-B4717A25-3960-45FB-B420-0B69226F9A35Q33759372-EE93C749-1BD9-4B21-8614-929142C59784Q33765414-DD2B540A-9657-4EBB-9F4A-0FC3E2BD3741Q33867014-FA5D2546-CFE6-4078-BE91-DE304B612937Q34293626-4740A58F-1693-4A0C-916A-E81557CE85F0Q34657739-8DC42365-B1D4-4652-BA52-156F0D80547FQ35005521-C19AA851-A1A3-4BC3-8DDB-EBA64E94282BQ35222618-5FD0473B-4E47-4F2A-BA8A-5FD86D966846Q35579053-CB2BCD27-CB01-4B75-AB74-A1910CF60C9DQ35788352-B2673985-ED91-4269-A7CD-A57C960CA0C7Q35990029-9E2305F4-93EC-4B56-89DE-4B834510025CQ36030868-196777E0-76AE-418C-A579-A3ABE00CBC26Q36088261-E345AB3F-704A-45F5-93BA-ECDD8AA576A5Q36384586-6B03EB41-2774-4C3C-849C-2D8DCC998FBDQ36565603-0DA98124-0D28-4FA1-9CA7-498E5395DC84Q36609724-411F2C20-60EB-40B5-81C7-1577100904ECQ36724890-D036448B-A77A-4FD8-9317-FB8F98A5990CQ36746313-97A479BA-45B9-43EF-8932-8FC45817173DQ36814295-458F628A-DA21-4FB9-96D9-D56CF53358FDQ36889043-D90505FE-A905-46BB-AAA5-6F4F136B650CQ36936061-72E169F6-4A55-408B-9622-7D257337CCFBQ37122001-1CAB5145-A7D6-42C4-9CFA-10090A7D8A81Q37330662-D91E1CB7-6148-4009-9B20-3186F055E8D0Q37355100-686AEE14-C3DA-40D4-8018-9C20CEABF460Q37479698-09107977-030D-404A-AC75-1BB63710B980Q37577041-09A83995-AB94-4BBA-A849-B5B2C11FB393Q37631412-27560338-E747-4468-9591-0168A51CDDB9Q37808230-D77CEAA1-DEC3-46F4-88F2-923DCBC4D5FFQ38084608-DE5A2511-33BB-401F-A2F8-AE9DECD9484EQ38723998-D18C98DF-CC96-420B-8EB3-3FD0673772F2Q39227575-90C5303C-61FC-448B-BA47-F0FC6C3642F4Q39533486-3924742D-1753-4A5A-B573-1FF3865F51A8Q39657323-926CB902-DB6F-430E-8771-9C6FFFD20F1E
P2860
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Tissue factor expression in br ...... osis and plasma concentration.
@ast
Tissue factor expression in br ...... osis and plasma concentration.
@en
type
label
Tissue factor expression in br ...... osis and plasma concentration.
@ast
Tissue factor expression in br ...... osis and plasma concentration.
@en
prefLabel
Tissue factor expression in br ...... osis and plasma concentration.
@ast
Tissue factor expression in br ...... osis and plasma concentration.
@en
P2093
P2860
P356
P1476
Tissue factor expression in br ...... osis and plasma concentration.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1272
P407
P577
2000-07-01T00:00:00Z
P5875
P6179
1052696136